Abstract
Percutaneous transluminal renal angioplasty (PTRA) is an invasive technique that is costly and involves the risk of complications and renal failure. The ability of PTRA to reduce the administration of antihypertensive drugs has been demonstrated. A potentially greater benefit, which nevertheless remains to be proven, is the deferral of the need for chronic dialysis. The aim of the study (ANPARIA) was to assess the appropriateness of PTRA to impact on the evolution of renal function. A standardized expert panel method was used to assess the appropriateness of medical treatment alone or medical treatment with revascularization in various clinical situations. The choice of revascularization by either PTRA or surgery was examined for each clinical situation. Analysis was based on a detailed literature review and on systematically elicited expert opinion, which were obtained during a two-round modified Delphi process. The study provides detailed responses on the appropriateness of PTRA for 1848 distinct clinical scenarios. Depending on the major clinical presentation, appropriateness of revascularization varied from 32% to 75% for individual scenarios (overal 48%). Uncertainty as to revascularization was 41% overall. When revascularization was appropriate, PTRA was favored over surgery in 94% of the scenarios, except in certain cases of aortic atheroma where sugery was the preferred choice. Kidney size >7 cm, absence of coexisting disease, acute renal failure, a high degree of stenosis (≥70%), and absence of multiple arteries were identified as predictive variables of favorable appropriateness ratings. Situations such as cardiac failure with pulmonary edema or acute thrombosis of the renal artery were defined as indications for PTRA. This study identified clinical situations in which PTRA or surgery are appropriate for renal artery disease. We built a decision tree which can be used via Internet: the ANPARIA software (http://www.chu-clermontferrand.fr/anparia/). In numerous clinical situations uncertainty remains as to whether PTRA prevents deterioration of renal function.
Similar content being viewed by others
References
Plouin PF, Chatellier G, Darne B, Raynaud A (1998) Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 31:823–829
Webster J, Marshall F, Abdalla M, et al. (1998) Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 12:329–335
van Jaarsveld BC, Krijnen P, Pieterman H, et al. (2000) The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 342:1007–1014
Textor SC (1996) Atherosclerotic renovascular disease as a cause of end-stage renal disease: cost considerations. Blood Purif 14:305–314
Rimmer JM, Gennari FJ (1993) Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 118:712–719
Greco BA, Breyer JA (1997) Atherosclerotic ischemic renal disease. Am J Kidney Dis 29:167–187
Guzman RP, Zierler RE, Isaacson JA, Bergelin RO, Strandness DE Jr (1994) Renal atrophy and arterial stenosis. A prospective study with duplex ultrasound. Hypertension 23:346–350
Dean RH, Tribble RW, Hansen KJ, O’Neil E, Craven TE, Redding JF 2nd (1991) Evolution of renal insufficiency in ischemic nephropathy. Ann Surg 213:446–455, discussion 455–456
Hansen KJ (1994) Prevalence of ischemic nephropathy in the atherosclerotic population. Am J Kidney Dis 24:615–621
Shanley PF (1996) The pathology of chronic renal ischemia. Semin Nephrol 16:21–32
Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT (1994) Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 24:622–629
Scoble J (1995) The epidemiology and clinical manifestations of atherosclerotic renal artery disease. In: Novick ASJ, Hamilton G (eds) Renal vascular disease. W. B. Saunders, London, pp 303–314
Preston RA, Epstein M (1997) Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertens 15:1365–1377
Harding MB, Smith LR, Himmelstein SI, et al. (1992) Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 2:1608–1616
Swartbol P, Parsson H, Thorvinger B, Norgren L (1994) To what extent does peripheral vascular disease and hypertension predict renal artery stenosis? Int Angiol 13:109–114
Caps MT, Perissinotto C, Zierler RE, et al. (1998) Prospective study of atherosclerotic disease progression in the renal artery. Circulation 98:2866–2872
Scoble JE, Hamilton G (1990) Atherosclerotic renovascular disease. BMJ 300:1670–1671
Weibull H, Bergqvist D, Bergentz SE, Jonsson K, Hulthen L, Manhem P (1993) Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg 18:841–850, discussion 850–852
Bakker J, Goffette PP, Henry M, et al. (1999) The Erasme study: a multicenter study on the safety and technical results of the Palmaz stent used for the treatment of atherosclerotic ostial renal artery stenosis. CardioVasc Interv Radiol 22:468–474
van de Ven PJ, Kaatee R, Beutler JJ, et al. (1999) Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 353:282–286
Radermacher J, Chavan A, Bleck J, et al. (2001) Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 344:410–417
Textor SC, Wilcox CS (2001) Renal artery stenosis: a common, treatable cause of renal failure? Annu Rev Med 52:421–442
Safian RD, Textor SC (2001) Renal-artery stenosis. N Engl J Med 344:431–442
Bernstein SJ, Kosecoff J, Gray D, Hampton JR, Brook RH (1993) The appropriateness of the use of cardiovascular procedures. British versus U.S. perspectives. Int J Technol Assess Health Care 9:3–10
McGlynn EA, Naylor CD, Anderson GM, et al. (1994) Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York State. JAMA 272:934–940
Pilpel D, Fraser GM, Kosecoff J, Weitzman S, Brook RH (1992) Regional differences in appropriateness of cholecystectomy in a prepaid health insurance system. Public Health Rev 20:61–74
Burnand B, Vader JP, Froehlich F, et al. (1998) Reliability of panel-based guidelines for colonoscopy: an international comparison. Gastrointest Endosc 47:162–166
Vader JP, Burnand B, Froehlich F, et al. (1997) Appropriateness of upper gastrointestinal endoscopy: comparison of American and Swiss criteria. Int J Qual Health Care 9:87–92
Brook RH, Kosecoff JB, Park RE, Chassin MR, Winslow CM, Hampton JR (1988) Diagnosis and treatment of coronary disease: comparison of doctors’ attitudes in the USA and the UK. Lancet 1:750–753
Fitch K, Bernstein SJ, Aguilar MD, et al. (2001) The RAND/UCLA Appropriateness Method user’s manual. MR 1269, DGXII RE. RAND Health/RAND Europe
Kahn KL, Kosecoff J, Chassin MR, et al. (1988) Measuring the clinical appropriateness of the use of a procedure. Can we do it? Med Care 26:415–422
Shekelle PG, Kahan JP, Bernstein SJ, Leape LL, Kamberg CJ, Park RE (1998) The reproducibility of a method to identify the overuse and underuse of medical procedures. N Engl J Med 338:1888–1895
Plouin PF, Alanore AL (1999) Management of the patient with atherosclerotic renal artery stenosis. New information from randomized trials. Nephrol Dial Transplant 14:1623–1626
Vader JP, Burnand B, Froehlich F, Dubois RW, Bochud M, Gonvers JJ (1999) The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE): project and methods. Endoscopy 31:572–578
Vader JP, Froehlich F, Dubois RW, et al. (1999) European Panel on the Appropriateness of Gastrointestinal Endoscopy (EPAGE): conclusion and WWW site. Endoscopy 31:687–694
Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE (1986) A method for the detailed assessment of the appropriateness of medical technologies. Int J Qual Health Care 2(1):53–63
Naylor CD (1998) What is appropriate care? N Engl J Med 338:1918–1920
Uder M, Humke U (2005) Endovascular therapy of renal artery stenosis: Where do we stand today? CardioVasc Interv Radiol 28(2):139–147
Acknowledgments
The project was funded by a national public grant from the French Ministry of Health (National Hospital Clinical Research Program 1997). We gratefully acknowledge the participation of the following clinical experts in the process: Xavier Barral, vascular surgery, Saint-Etienne; Alain Barret, vascular surgery, Toulouse; Jean-Paul Beregi, radiology, Lille; Louis Boyer, radiology, Clermont-Ferrand; Issam Farah, vascular surgery, Grenoble; Albert Fournier, nephrology, Amiens; Francis Joffre, radiology , Toulouse; Michel Lacombe, vascular surgery, Paris; Denis Lyonnet, radiology, Lyon; Alain Meyrier, nephrology, Paris; Bruno Moulin, nephrology, Strasbourg; Pierre-François Plouin, cardiology, Paris; Alain Raynaud, radiology, Paris; Bernard Waeber , nephrology, Lausanne.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gerbaud, L., Manhes, G., Debourse, J. et al. The Appropriateness of Renal Angioplasty. The ANPARIA Software: A Multidisciplinary Expert Panel Approach. Cardiovasc Intervent Radiol 31, 1059–1068 (2008). https://doi.org/10.1007/s00270-007-9178-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-007-9178-3